Folgen
Leila Zarei
Leila Zarei
Assistant Professor of Pharmacoeconomics and Pharmaceutical Administration, Shiraz University of
Bestätigte E-Mail-Adresse bei sums.ac.ir
Titel
Zitiert von
Zitiert von
Jahr
The effects of corporate social responsibility on organizational performance in the Iranian pharmaceutical industry: The mediating role of TQM
G Mehralian, JA Nazari, L Zarei, HR Rasekh
Journal of cleaner production 135, 689-698, 2016
1822016
The effect of risk communication on preventive and protective Behaviours during the COVID-19 outbreak: mediating role of risk perception
ST Heydari, L Zarei, AK Sadati, N Moradi, M Akbari, G Mehralian, ...
BMC public health 21, 1-11, 2021
1452021
Nursing experiences of COVID‐19 outbreak in Iran: A qualitative study
A Kalateh Sadati, L Zarei, S Shahabi, ST Heydari, V Taheri, R Jiriaei, ...
Nursing open 8 (1), 72-79, 2021
1422021
Mental health status during COVID-19 pandemic in Fars Province, Iran: timely measures
A Mani, AR Estedlal, M Kamali, SZ Ghaemi, L Zarei, N Shokrpour, ...
BMC Public Health 20, 1-11, 2020
252020
Burnout among nurses during coronavirus disease 2019 outbreak in Shiraz
M Kamali, AK Sadati, MR Khademi, S Ghahramani, L Zarei, SZ Ghaemi, ...
Galen Medical Journal 9, e1956, 2020
232020
Willingness to pay for one quality-adjusted life year in Iran
N Moradi, A Rashidian, S Nosratnejad, A Olyaeemanesh, M Zanganeh, ...
Cost Effectiveness and Resource Allocation 17, 1-10, 2019
202019
Expectations of citizens from the government in response to COVID-19 pandemic: a cross-sectional study in Iran
L Zarei, S Shahabi, AK Sadati, R Tabrizi, ST Heydari, KB Lankarani
BMC public health 21, 1-10, 2021
192021
Evaluation of the indicators of hospital information system
M Amiresmaili, L Zarei, E Sheibani, A Arabpur
Health Information Management 10 (129), 1-13, 2013
152013
Public sphere attitudes towards the rumor sources of the COVID-19 pandemic: evidence from community perceptions in Iran
M Banakar, AK Sadati, L Zarei, S Shahabi, ST Heydari, KB Lankarani
BMC Public Health 21, 1-9, 2021
142021
Recommendations to improve insurance coverage for physiotherapy services in Iran: a multi criteria decision-making approach
S Shahabi, D Skempes, M Behzadifar, R Tabrizi, B Nazari, MK Ghanbari, ...
Cost Effectiveness and Resource Allocation 19, 1-15, 2021
122021
The common concerns regarding the COVID-19 outbreak in Iran: Explored findings from a qualitative study
S Shahabi, AK Sadati, L Zarei, M Noroozi, R Tabrizi, ST Heydari, ...
122020
The worth of a quality-adjusted life-year in patients with diabetes: an investigation study using a willingness-to-pay method
N Moradi, A Rashidian, S Nosratnejad, A Olyaeemanesh, M Zanganeh, ...
PharmacoEconomics-open 3, 311-319, 2019
122019
The prevalence and risk factors of death anxiety and fear of COVID‐19 in an Iranian community: A cross‐sectional study
A Mani, R Fereidooni, M Salehi‐Marzijarani, A Ardekani, S Sasannia, ...
Health science reports 5 (4), e706, 2022
112022
Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries
A Kadkhodamanesh, V Varahrami, L Zarei, F Peiravian, M Hadidi, ...
Journal of Pharmaceutical Policy and Practice 14 (1), 82, 2021
112021
An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country
A Moosivand, M Rangchian, L Zarei, F Peiravian, G Mehralian, ...
Journal of Pharmaceutical Health Care and Sciences 7, 1-11, 2021
102021
Affordability of medication therapy in diabetic patients: a scenario-based assessment in Iran’s health system context
L Zarei, P Peymani, N Moradi, M Kheirandish, M Mirjalili, M Zare
International Journal of Health Policy and Management 11 (4), 443, 2022
92022
An application of analytic network process model in supporting decision making to address pharmaceutical shortage
L Zarei, N Moradi, F Peiravian, G Mehralian
BMC health services research 20, 1-11, 2020
82020
Does CSR matter in the pharmaceutical distribution industry? The balanced scorecard perspective
G Mehralian, L Zarei, M Akhgari, M Peikanpour
International Journal of Pharmaceutical and Healthcare Marketing 13 (2), 228-243, 2019
82019
Private demand for Covid-19 vaccine: a contingent assessment from a low-and middle-income country
Z Meshkani, L Zarei, N Hajimoladarvish, J Arabloo, A Rezapour, H Farabi, ...
Iranian journal of pharmaceutical research: IJPR 20 (3), 223, 2021
72021
The scarce drugs allocation indicators in Iran: a Fuzzy Delphi Method based consensus
L Zarei, F Peiravian, MS Pishvaee, B Aghababaei
Iranian Journal of Pharmaceutical Research: IJPR 18 (2), 1126, 2019
72019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20